Web2. What you need to know before you use innohep® 3. How to use innohep® 4. Possible side effects 5. How to store innohep® 6. innohep should not be interchanged with other … WebInnohep side effects. All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects …
TINZAPARIN - INJECTION side effects, medical uses, and ... - MedicineNet
Web1. what innohep® is and what it is used for. innohep is a type of heparin – a low molecular weight heparin – and belongs to a group of medicines called anticoagulants; these medicines affect how your blood clots. innohep prevents clotting, allowing normal blood flow through the arteries and veins. WebSide Effects & Adverse Reactions INNOHEP® is not intended for intramuscular or intravenous administration. INNOHEP® cannot be used interchangeably (unit for unit) with heparin or other low molecular weight heparins as they differ in manufacturing process, molecular weight distribution, anti-Xa and anti-IIa activities, units, and dosage. canadian latin heritage association
Innohep 4500 IU Injection - Uses, Dosage, Side Effects, …
WebShould you wish, you can also report any suspected side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL- Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; Email: [email protected]. By reporting side effects you can help provide more information on the safety of this medicine. Patients previously exposed to unfractionated heparin or a low-molecular-weight heparin appear to be more susceptible to developing heparin-induced thrombocytopenia (HIT) and HIT-related thromboembolic complications (e.g., transient ischemic attack, stroke) than those who were never … See more Cardiovascular side effects including chest pain (2.3%), hypotension (greater than 1%), tachycardia (greater than 1%), hypertension (greater than 1%), and angina pectoris (greater than 1%) have been reported. Other side … See more Hepatic side effects including cholestatic hepatitis and increases in hepatic enzymes have been reported in ongoing or completed clinical … See more A 66-year-old man with end-stage renal disease (who had been receiving dialysis for about a year) complained of hair loss from the right temporal area. He had been taking enoxaparin for … See more Respiratory tract symptoms including pulmonary embolism (2.3%) and dyspnea (1.2%) have been reported.[Ref] See more WebAdult Dosage. The recommended dose of Innohep-3500® for the treatment of DVT with or without PE is 175 anti-Xa IU/kg of body weight, administered SC once daily for at least 6 days and until the patient is adequately anticoagulated with warfarin (INR at least 2.0 for two consecutive days). Warfarin sodium therapy should be initiated when ... canadian last names girls